Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has shared an announcement.
Dawnrays Pharmaceutical Holdings Ltd. has announced a board meeting scheduled for August 22, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the declaration of an interim dividend, reflecting the company’s ongoing financial assessment and potential shareholder returns.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development, manufacture, and sale of pharmaceutical products, serving various market needs.
Average Trading Volume: 2,115,131
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$2.04B
See more data about 2348 stock on TipRanks’ Stock Analysis page.